VIROPRO INC. 
By Irvine CA, Monday, June 6, VIROPRO (PK: VPRO). At the coming stockholders meeting, the Company will seek approval to change its name. Management believes the
Share
© Publicnow - 2011
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | -.--% |
| 2016 | Viropro Inc. Announces Resignation of Kenneth Sorensen as Board of Director | CI |
| 2016 | Viropro Seeks Acquisitions | CI |
Viropro, Inc. is engaged in the development and manufacturing of biopharmaceutical drugs. The Company conducts operations primarily through its subsidiary, Alpha Biologics Sdn Bhd (Alpha) located in Penang, Malaysia. The Company intends to offer solution to the biopharma industry from drug concept through to product manufacturing. The Alpha facility consists of approximately 50,000 square feet of research and production space. The Alpha facility is designed to support the scale-up and manufacture of monoclonal antibodies.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 1.27K | |
| +9.58% | 115B | |
| +12.41% | 106B | |
| -2.59% | 21.96B | |
| -12.38% | 21.87B | |
| -5.29% | 19.21B | |
| -3.35% | 18.08B | |
| -38.57% | 17.71B | |
| +7.51% | 14.32B | |
| +35.67% | 12.42B |
- Stock Market
- Equities
- VPRO Stock
- News Viropro Inc.
- VIROPRO : changes name